UroGen Pharma 所有権

大株主は誰で、インサイダーは売買しているのか？

最近のインサイダー取引

NasdaqGM:URGN 企業または個人による最近のインサイダー取引
日付	価値	名称	エンティティ	株式	最高価格
18 Mar 24	SellUS$168,600	Mark Schoenberg	Individual	12,000	US$14.05
01 Feb 24	SellUS$78,790	Jason Smith	Individual	4,993	US$15.78
01 Feb 24	SellUS$59,790	Mark Schoenberg	Individual	3,789	US$15.78

インサイダー取引量

インサイダー購入: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

所有権の内訳

URGN の所有者構成は？
オーナータイプ	株式数	所有比率
個人インサイダー	2,328,019	5.04%
VC/PEファーム	5,989,689	13%
ヘッジファンド	9,351,573	20.2%
機関	28,538,368	61.8%

株式の希薄化: Shareholders have been diluted in the past year, with total shares outstanding growing by 36.7%.

上位株主

25 上位株主94.33 ％を所有。

所有権	名称	株式	現在の価値	変化率	ポートフォリオ
8.45%	RTW Investments, LP	3,557,347	US$43.4m	9.21%	0.65%
7.84%	Adage Capital Management, L.P.	3,300,000	US$40.3m	154%	0.07%
7.32%	RA Capital Management, L.P.	3,083,430	US$37.6m	0%	0.42%
6.9%	Great Point Partners, LLC	2,906,259	US$35.5m	10.9%	6.54%
5.93%	BlackRock, Inc.	2,497,943	US$30.5m	13.9%	データなし
5.92%	Point72 Asset Management, L.P.	2,494,226	US$30.4m	123%	0.07%
5.47%	Menora Mivtachim Pensions & Gemel Ltd.	2,303,031	US$28.1m	0%	0.15%
4.99%	Cowen Inc,Private Banking and Investment Banking Investments	2,099,482	US$25.6m	29.1%	0.64%
4.34%	Morgan Stanley, Investment Banking and Brokerage Investments	1,826,649	US$22.3m	380%	データなし
3.92%	Cormorant Asset Management, LP	1,650,000	US$20.1m	0%	0.92%
3.73%	Monograph Capital Partners	1,572,327	US$19.2m	0%	データなし
3.53%	Pontifax Venture Capital	1,487,669	US$18.1m	0%	6.02%
3.25%	Moshe Arkin	1,369,315	US$16.7m	0%	データなし
3.16%	UBS Asset Management AG	1,331,887	US$16.2m	3,010%	データなし
2.85%	Credit Suisse Asset Management (Switzerland) Ltd.	1,200,000	US$14.6m	0%	0.01%
2.76%	Millennium Management LLC	1,160,899	US$14.2m	2,670%	0.01%
2.62%	Silverarc Capital Management, LLC	1,102,000	US$13.4m	117%	3.36%
2.29%	Jefferies Financial Group Inc.,Asset Management Arm	965,000	US$11.8m	14.9%	0.25%
1.73%	State Street Global Advisors, Inc.	726,676	US$8.9m	35.3%	データなし
1.63%	Migdal Mutual Funds Ltd.	686,472	US$8.4m	0%	0.07%
1.32%	Medical Strategy GmbH, Asset Management Arm	555,223	US$6.8m	30.4%	0.4%
1.18%	Wildcat Capital Management, LLC	495,606	US$6.0m	0%	1.2%
1.11%	Dafna Capital Management, LLC	469,000	US$5.7m	0%	1.34%
1.1%	Harel Insurance Investments and Finances Services Ltd, Asset Management Arm	463,267	US$5.7m	-0.06%	0.06%
1%	Geode Capital Management, LLC	421,389	US$5.1m	30.1%	データなし